Heliyon · 2024 · 10 citations · 40 references
MedicineBiostatisticsClinical SciencesClinical CardiologyMolecular DiagnosticsPrecision MedicineAcute Ischemic StrokeCardiovascular DiseaseCerebrovascular DiseaseStrokeBiomarkersCross-sectional EpidemiologyDiagnostic Performance MetricsEarly DiagnosisIschemic Stroke PrognosticationStroke BiomarkersStroke Screening ToolsThrombosis Biomarkers
Background: Ischemic stroke is a common type of stroke that leads to death and functional disability in hypertensive patients. However, there are no well-studied non-invasive and less expensive fluid biomarkers routinely used to detect ischemic stroke in hypertensive patients. Hence, this study aimed to tease out the performance of D-dimer, fibrinogen, and the D-dimer to fibrinogen ratio (DDFR) in predicting hypertension-associated acute ischemic stroke. Methods: A hospital-based cross-sectional study was done from October 2022 to January 2022 at Yikatit 12 Hospital Medical College, Ethiopia. We recruited 55 hypertensive patients who had an ischemic stroke and 110 who did not. A ROC curve was used to calculate the areas under the curves (AUCs) and determine the diagnostic power of the D-dimer, fibrinogen, and DDFR. The Youden index was used to find the best cut-off points for biomarkers in detecting acute ischemic stroke. A De Long test was employed to show whether there was a significant difference between the AUCs of biomarkers in diagnosing ischemic stroke. Results: D-dimer yielded the highest diagnostic power (AUC = 0.776) in detecting acute ischemic stroke, followed by DDFR (AUC = 0.763) and fibrinogen (AUC = 0.694), but there was no significant difference between them. At 0.52 μg/ml cut-off point, D-dimer had 82.9% sensitivity, 66.7% specificity, 62.5% PPV, and 85.3% NPV to diagnose acute ischemic stroke. Fibrinogen could detect acute ischemic stroke at 405.85 mg/dl level, with 70.0% sensitivity, 57.1% specificity, 41.2% PPV and 81.6% NPV. At a 1.83 ratio, DDFR might also identify ischemic stroke with 80.0% sensitivity, 67.1% specificity, 51.1% PPV, and 88.7% NPV. Conclusion: We showed D-dimer, fibrinogen, and DDFR as promising, affordable, and non-invasive biomarkers for the detection of ischemic stroke among subjects with hypertension. This will help clinicians make an early diagnosis and better guide patient therapy.
40
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022
Valery L. Feigin, Michael Brainin, Bo Norrving et al. · International Journal of Stroke · 2022 · 2.8K citations
Non-invasive diagnosis of venous thromboembolism in outpatients
Arnaud Perrier, Sylvie Desmarais, Marie‐José Miron et al. · The Lancet · 1999 · 796 citations
Guidelines on fibrinogen assays
Ian Mackie, Steven Kitchen, Samuel J. Machin et al. · British Journal of Haematology · 2003 · 294 citations · Full text